FME.DE
FME.DE
DE0005785802
Fresenius Medical Care AG I
Loading chart...

Company Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company operates through Care Delivery and Care Enablement segments. It also develops, manufactures, and distributes various health care products, including hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular specialty, ambulatory surgery center, physician nephrology practice management, pharmacy and other services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics, as well as through local sales forces, independent distributors, dealers, and sales agents. The company was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Related stocks

FMS
FMS • Germany
Fresenius Medical Care AG
21.06 USD
11.21B USD 1Y -22.9%
FRE.DE
FRE.DE • Germany
Fresenius SE & Co. KGaA N
42.36 EUR
26.73B USD 1Y -12.5%
FRE.DE
FRE.DE • Germany
Fresenius SE & Co. KGaA N
42.36 EUR
26.73B USD 1Y -12.5%
MCOV-B.ST
MCOV-B.ST • Sweden
Medicover AB ser. B
263.5 SEK
4.01B USD 1Y -0.8%
DVA
DVA • United States
DaVita Inc.
179.25 USD
11.51B USD 1Y +38.4%
EMEIS.PA
EMEIS.PA • France
EMEIS
10.05 EUR
1.81B USD 1Y -32.2%
ATT.ST
ATT.ST • Sweden
Attendo AB
120 SEK
1.68B USD 1Y +76.1%
CLARI.PA
CLARI.PA • France
CLARIANE SE
3.32 EUR
1.33B USD 1Y -28.2%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
31.5% p.a.
Max Drawdown (5Y)
-58.7%
Sharpe Ratio (5Y)
-0.38
Beta Factor
0.81
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (31.5% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -71.8% in the extended horizon.
ende